Ellen Rosenberg - 18 Dec 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Legal Officer
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
4
Filing time
19 Dec 2023, 17:56:53 UTC
Previous filing
25 Jan 2023
Next filing
28 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award $0 +9,940 +3% $0.000000 342,285 18 Dec 2023 Direct F1
holding FOLD Common Stock 15,000 18 Dec 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a contingent right to receive common stock in the amount shown, for no consideration, due to the satisfaction of performance criteria underlying an award of performance based restricted stock units granted in 2021. Such units remain outstanding on the date hereof and will fully vest on December 31, 2023, subject to the Reporting Person's continued service with the Company.